This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Beerepoot, L. V. Articles by Voest, E. E. Search for Related Content PubMed PubMed Citation Articles by Beerepoot, L. V. Articles by Voest, E. E.

Up-Regulation of Vascular Endothelial Growth Factor Production by Iron Chelators

Department of Internal Medicine and Medical Oncology, University Hospital Utrecht, P. O. Box 85500, 3508 GA Utrecht, the Netherlands [L. V. B., E. E. V.]; Department of Surgery, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115 [D. T. S., M. K.]; and Department of Pathology, Dartmouth-Hitchock Medical Center, Lebanon, New Hampshire 03756 [K-T. Y.]

Agents that modulate cellular iron availability have been studied for their antitumor activity. Based on encouraging in vitro studies, the iron chelator deferoxamine (DFO) has been used in clinical studies to treat cancer patients. The observation that DFO induced macular edema in several cancer patients led to the present investigation of vascular endothelial growth factor (VEGF) as a possible mediator of the encountered side effects. Both normal and malignant cell lines were incubated with DFO and a variety of other iron chelators. DFO, at concentrations achievable in humans, induced a 3-5-fold increase in VEGF mRNA expression in all cell lines studied. This increased VEGF mRNA expression was dose and time dependent. A panel of structurally different iron chelators induced an even more potent increase in VEGF mRNA expression. The DFO-induced increase in VEGF mRNA expression translated into 6- and 4-fold increases in VEGF protein secretion in conditioned media of retinal pigment epithelial and C6 glioblastoma cells, respectively. These findings suggest that VEGF may act as a mediator of the side effects induced by iron chelation therapy. In addition, because VEGF is an important regulator of angiogenesis, iron chelators should be given with caution to cancer patients.

¹ A fellow of the Dutch Cancer Society. To whom requests for reprints should be addressed. Phone: 31-30-2506265; Fax: 31-30-2518328.

Received 1/ 3/96. Accepted 4/18/96.

This article has been cited by other articles:

				X. Xu, R. Sutak, and D. R. Richardson Iron Chelation by Clinically Relevant Anthracyclines: Alteration in Expression of Iron-Regulated Genes and Atypical Changes in Intracellular Iron Distribution and Trafficking Mol. Pharmacol., March 1, 2008; 73(3): 833 - 844. [Abstract] [Full Text] [PDF]

				D. T. Jones, I. S. Trowbridge, and A. L. Harris Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate. Cancer Res., March 1, 2006; 66(5): 2749 - 2756. [Abstract] [Full Text] [PDF]

				I. Sheikh, G. Tchekanov, D. Krum, J. Hare, M. Djelmami-Hani, R. Maddikunta, M. E. Mortada, P. Karakozov, I. Baibekov, J. Hauck, et al. Effect of Electrical Stimulation on Arteriogenesis and Angiogenesis after Bilateral Femoral Artery Excision in the Rabbit Hind-Limb Ischemia Model Vascular and Endovascular Surgery, May 1, 2005; 39(3): 257 - 265. [Abstract] [PDF]

				V. S Chekanov, M. Zargarian, I. Baibekov, P. Karakozov, G. Tchekanov, J. Hare, V. Nikolaychik, T. Bajwa, and M. Akhtar Deferoxamine-fibrin accelerates angiogenesis in a rabbit model of peripheral ischemia Vascular Medicine, August 1, 2003; 8(3): 157 - 162. [Abstract] [PDF]

				V. S. Chekanov, V. Nikolaychik, M. A. Maternowski, R. Mehran, M. B. Leon, M. Adamian, J. Moses, G. Dangas, N. Kipshidze, and M. Akhtar Deferoxamine enhances neovascularization and recovery of ischemic skeletal muscle in an experimental sheep model Ann. Thorac. Surg., January 1, 2003; 75(1): 184 - 189. [Abstract] [Full Text] [PDF]

				L. E. Benjamin Glucose, VEGF-A, and Diabetic Complications Am. J. Pathol., April 1, 2001; 158(4): 1181 - 1184. [Full Text] [PDF]

				M. V. Panchenko, H. W. Farber, and J. H. Korn Induction of heme oxygenase-1 by hypoxia and free radicals in human dermal fibroblasts Am J Physiol Cell Physiol, January 1, 2000; 278(1): C92 - C101. [Abstract] [Full Text] [PDF]